You are here

GlycoMimetics

Pfizer uncouples from GlycoMimetics and its failed sickle cell disease drug

Endpoints

Tue, 02/11/20 - 10:39 am

sickle cell disease

Next up for GlycoMimetics after tanking in sickle cell disease

BioCentury

Mon, 08/5/19 - 10:32 pm

GlycoMimetics shares crash after Pfizer team dismisses their lead drug as a PhIII failure

Endpoints

Mon, 08/5/19 - 12:03 am

sickle cell disease

5 Biotech Stocks That Could Be Bought Out in 2018

Yahoo/Motley Fool

Sun, 01/14/18 - 09:38 am

Portola Pharmaceuticals

Esperion Therapeutics

Here's Why GlycoMimetics Could Become a Takeover Target

Yahoo/Motley Fool

Sun, 12/17/17 - 11:36 am

acute myeloid leukemia

GlycoMimetics: A Promising Sickle Cell Disease Play

Seeking Alpha

Thu, 04/10/14 - 10:35 am

sickle cell disease

Biotech IPOs: Class of 2014 still rolling as investors line up to cash in

Fierce Biotech

Fri, 02/14/14 - 01:09 pm

Dicerna Pharmaceuticals

Revance Therapeutics

GlycoMimetics, Karyopharm ride the wave of new biotech IPOs

Fierce Biotech

Mon, 10/7/13 - 09:00 am

sickle cell disease

Orphan drug status granted for GMI-1070 in Europe

Yahoo/Fly on the Wall

Fri, 09/13/13 - 08:28 am

sickle cell anemia